Appello Pharmaceuticals, Inc.
1 clinical trials · Sponsor
◉ Watch Appello Pharmaceuticals, Inc.
| Record | Firm | Date |
|---|---|---|
| A Study to Evaluate the Effectiveness of Two Doses of AP-472 as Adjunctive Therapy to Levodopa in Parkinson's Disease (PD) Participants With Motor Fluctuations (NCT07432958) | Appello Pharmaceuticals, Inc. | 2026-02-25 |
Track Appello Pharmaceuticals, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.